Nuclera
Nuclera is a biotechnology company that develops and manufactures rapid protein prototyping systems for scientific research.
The UK Home Office lists Nuclera as a licensed sponsor (A-rated, Skilled Worker route). They can sponsor work visas. We read every advert and list only roles that don't rule out sponsorship. Home Office figures released under the Freedom of Information Act show Nuclera assigned 19 Certificates of Sponsorship in 2021–24 for Skilled Worker and Global Business Mobility visas. We're showing 2 of their current openings.
Sponsor licence details
Sourced from the UK Home Office register of licensed sponsors.
Sponsorship history
Certificates of Sponsorship Nuclera assigned each year, from Home Office figures released under the Freedom of Information Act.
Skilled Worker and Global Business Mobility routes. One certificate is assigned for each sponsored hire, visa extension or change of employer, so a person can be counted more than once. “1–5” is withheld by the Home Office; the 2025 figures list only sponsors with 5 or more (“—”). Matched to this employer by its name on the sponsor register. Sources: FOI 2025/12841 (2021–24), FOI2026/03501 (2025). Contains public sector information licensed under the Open Government Licence v3.0.
About Nuclera
Nuclera is a biotechnology and healthcare company that develops rapid protein prototyping technologies. Its main product is the eProtein Discovery system, an automated benchtop platform that combines cell-free protein synthesis with digital microfluidics. This system enables researchers to perform in-house protein design, screening, characterisation, and expression within a short timeframe.
The company serves sectors such as drug discovery, structural biology, and academic research. Its technology automates parallel screens to identify soluble, high-yield proteins and antibody fragments in less than forty-eight hours, replacing slow, iterative manual laboratory methods with a digital workflow.
Open roles
2 live positions matched to this sponsor licence.